Company: AMTX
Filing Date: 2025-11-07
Form Type: 10-Q
Source: 0001437749-25-033667
Chunk: 2

Company: AEMETIS, INC
Filing Date: 2025-11-07
Form: 10-Q
Item: Part I, Item 1
Chunk 2
---
,425
      )

       Financing activities: 

       Proceeds from borrowings 

      29,246

      12,534

       Repayments of borrowings 

      (35,729
      )

      (4,841
      )

       Payments on Series A preferred financing 

      (2,200
      )

      -

       Lender debt renewal and waiver fee payments 

      (495
      )

      (1,445
      )

       Payments on finance leases 

      (168
      )

      (170
      )

       Proceeds from sales of common stock 

      25,487

      21,680

       Proceeds from exercise of stock options 

      257

      36

       Net cash provided by financing activities 

      16,398

      27,794

       Effect of exchange rate changes on cash, cash equivalents, and restricted cash 

      (138
      )

      (4
      )

       Net change in cash, cash equivalents, and restricted cash for period 

      4,721

      (2,987
      )

       Cash, cash equivalents, and restricted cash at beginning of period 

      3,831

      6,280

       Cash, cash equivalents and restricted cash at end of period 
       
      $
      8,552

      $
      3,293

       Supplemental disclosures of cash flow information, cash paid: 

       Cash paid for interest 
       
      $
      12,820

      $
      6,272

       Income taxes paid 

      -

      878

       Supplemental disclosures of cash flow information, non-cash transactions: 

       Settlement of Accounts Payable via issuance of Common Stock 

      45

      -

       Subordinated debt extension fees added to debt 

      680

      680

       Fair value of warrants issued to subordinated debt holders 

      584

      916

       Lender debt extension, waiver, and other fees added to debt 

      2,595

      695

       Cumulative capital expenditures in accounts payable and accruals 

      17,228

      10,060

The accompanying notes are an integral part of the financial statements.

       6

AEMETIS, INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT

(Unaudited, in thousands)

       For the nine months ended September 30, 202